FDA to crack down on menthol cigarettes, flavored vapes
The move represents a major step to further push down U.S. smoking rates, which have been falling for decades.
The move represents a major step to further push down U.S. smoking rates, which have been falling for decades.
Trucking insurer Protective Insurance Corp., long known as Baldwin & Lyons, has skidded into red ink and now is pursuing “potential strategic partnerships or transactions.“
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
MiraVista Diagnostics, which processes more than 100,000 fungal-infection tests annually, plans to double the size of its headquarters near Indianapolis International Airport.
On average, the premium for typical plans in the 39 states that use the federal healthcare.gov website will drop 1.5 percent.
Carmel-based insurance holding company CNO Financial Group Inc. on Wednesday reported a big third-quarter loss despite sales growth in all three of its business units.
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
Much of the insurance left on the Affordable Care Act marketplaces limits patients to narrow networks of hospitals or doctors and provides no coverage outside those networks.
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
The plan approved by Purdue trustees on Oct. 12 met widespread opposition from faculty and staff.
Indiana lawmakers listened to more than three hours of testimony Thursday afternoon about whether Indiana should allow for medical marijuana usage but did not come to any consensus on the issue.
One year ago, Indiana-based Endocyte Inc. bought the rights to a prostate cancer treatment for $12 million, plus future considerations. On Thursday, Novartis AG agreed to pay almost 200 times that amount to acquire Endocyte and the experimental therapy.
The Indiana Seed Fund III is an early-stage fund focused on developing startups in life sciences, health IT and agricultural biosciences.
The physicians’ group claims the Connersville health system misled it on patient volumes and has refused to adjust a subsidy to make up the difference.
The Justice Department’s approval clears the way for a merger that will create a health care giant with a hand in insurance, prescription-drug benefits and drugstores across the United States.
The U.S. Food and Drug Administration will make it easier for pharmaceutical companies to bring more complex—and more profitable—generic drugs to market, throwing the struggling industry a crucial lifeline.
Visits to emergency rooms in Indiana for drug overdoses are falling, and doctors are writing fewer prescriptions for opioid painkillers, Jim McClelland said Friday.